eftilagimod alfa — Conference presentation
Oct 23–Oct 27
An abstract containing health-related quality of life (HRQoL) data from the EFTISARC-NEO trial has been accepted for presentation at the ESMO Congress 2026 in October 2026.Source filing
IMMP biotech catalysts & pipeline
IMMUTEP LTD · Data as of 2026-09-08